Strong age dependent increase in the use of adjuvant systemic treatment for early stage breast cancer in the period 1990-2006: a population based analysis

被引：0
|
作者：
Sukef, M. P. P. [1 ]
van de Poll-Franse, L. V. [2 ]
Nieuwenhuijzen, G. A. P. [3 ]
Vreugdenhil, A. [4 ]
Herings, R. M. C. [1 ]
Coebergh, J. W. W. [2 ]
Voogd, A. C. [5 ]
机构：
[1] PHARMO Inst Drug Outcomes Res, Utrecht, Netherlands
[2] Comprehens Canc Ctr S, Eindhoven, Netherlands
[3] Catharina Hosp, Eindhoven, Netherlands
[4] Maxima Medisch Centrum, Veldhoven, Netherlands
[5] Maastricht Univ, Maastricht, Netherlands
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 07期
关键词：
D O I：
10.1016/S1359-6349(08)70569-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：123 / 123
页数：1
相关论文
共 50 条
  • [21] Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study
    Jeanne Debess
    Jens Østergaard Riis
    Malene Cramer Engebjerg
    Marianne Ewertz
    Breast Cancer Research and Treatment, 2010, 121 : 91 - 100
  • [22] Time trends in population-based breast cancer survival in Estonia: Analysis by age and stage
    Baburin, Aleksei
    Aareleid, Tiiu
    Padrik, Peeter
    Valvere, Vahur
    Innos, Kaire
    ACTA ONCOLOGICA, 2014, 53 (02) : 226 - 234
  • [23] Time trends in population-based breast cancer survival in Estonia: Analysis by age and stage
    Innos, K.
    Baburin, A.
    Valvere, V.
    Aareleid, T.
    Padrik, P.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S304 - S305
  • [24] Use of systemic therapy for early stage breast cancer in older adults: Results from the Bridging the Age Gap study
    Battisti, Nicolo Matteo Luca
    Ring, Alistair
    Bradburn, Mike
    Wyld, Lynda
    CANCER RESEARCH, 2020, 80 (04)
  • [25] Impact of treatment regimen on acute care use during and after adjuvant chemotherapy for early-stage breast cancer
    Ruddy, Kathryn J.
    Van Houten, Holly K.
    Sangaralingham, Lindsey R.
    Freedman, Rachel A.
    Thompson, Carrie A.
    Hashmi, Shahrukh K.
    Jemal, Ahmedin
    Haddad, Tufia C.
    Mougalian, Sarah
    Herrin, Jeph
    Gross, Cary
    Shah, Nilay
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 164 (03) : 515 - 525
  • [26] Impact of treatment regimen on acute care use during and after adjuvant chemotherapy for early-stage breast cancer
    Kathryn J. Ruddy
    Holly K. Van Houten
    Lindsey R. Sangaralingham
    Rachel A. Freedman
    Carrie A. Thompson
    Shahrukh K. Hashmi
    Ahmedin Jemal
    Tufia C. Haddad
    Sarah Mougalian
    Jeph Herrin
    Cary Gross
    Nilay Shah
    Breast Cancer Research and Treatment, 2017, 164 : 515 - 525
  • [27] Outcomes of women with early stage HER-2 over-expressing breast cancer receiving adjuvant trastuzumab: a population based analysis
    Chia, S.
    Speers, C.
    Gelmon, K.
    Ellard, S.
    Pickering, R.
    O'Reilly, S.
    Seal, M.
    EJC SUPPLEMENTS, 2010, 8 (03): : 59 - 60
  • [28] Population-Based Comparison of CEF and AC/T, Two Adjuvant Chemotherapy 'Standards' for Early Stage Breast Cancer
    Al-Tourah, A. J.
    Woods, R.
    Norris, B. D.
    Speers, C. H.
    Kennecke, H. F.
    CANCER RESEARCH, 2009, 69 (24) : 620S - 620S
  • [29] Duration and Toxicity of Adjuvant Trastuzumab in Older Patients With Early-Stage Breast Cancer: A Population-Based Study
    Vaz-Luis, Ines
    Keating, Nancy L.
    Lin, Nancy U.
    Lii, Huichuan
    Winer, Eric P.
    Freedman, Rachel A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (09) : 927 - +
  • [30] Temporal trends in the use of adjuvant systemic therapy in breast cancer - a population based study in Sweden 1976-2005
    Kemetli, Levent
    Rutqvist, Lars Erik
    Jonsson, Hakan
    Nystrom, Lennarth
    Lenner, Per
    Tornberg, Sven
    ACTA ONCOLOGICA, 2009, 48 (01) : 59 - 66
12345